Jiangsu Lanfeng Bio-chemicalLtd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	1.3yrs
Board average tenure	1.3yrs

Recent management updates

Recent updates

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry

Nov 09

Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price

Sep 25

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Jun 07

The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%

Feb 29

CEO

Jiangsu Lanfeng Bio-chemicalLtd has no CEO, or we have no data on them.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jun Xing	Deputy GM	1.3yrs	CN¥442.10k	no data
Haijun Tang	Deputy GM & Board Secretary	1.3yrs	CN¥541.90k	0.35% CN¥ 7.8m
Anping Liu	Deputy General Manager	1.3yrs	CN¥1.07m	0.36% CN¥ 8.0m

1.3yrs

Average Tenure

51yo

Average Age

Experienced Management: 002513's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Jian Yuan	Independent Director	1.3yrs	CN¥84.50k	no data
Xu Zheng	Chairman of the Board	1.3yrs	CN¥488.90k	17.98% CN¥ 398.0m
Zhonglin Lu	Non-Independent Director	1.3yrs	CN¥400.10k	no data
Haifeng Cui	Vice Chairman	1.3yrs	CN¥209.80k	no data
Xingchong Liu	Independent Director	1.3yrs	CN¥42.50k	no data
Jian Tang	Independent Director	1.3yrs	CN¥42.50k	no data
Junli Ren	Non-Employee Supervisor	1.3yrs	no data	no data
Yichen Han	Chairman of the Supervisory Board	1.3yrs	no data	no data

1.3yrs

Average Tenure

43yo

Average Age

Experienced Board: 002513's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Jiangsu Lanfeng Bio-chemicalLtd Management

Management criteria checks 0/4

Key information

Recent management updates

Jiangsu Lanfeng Bio-chemical Co.,Ltd, Annual General Meeting, May 23, 2024

Jiangsu Lanfeng Bio-Chemical Co.,Ltd Approves Management Elections

Less than half of directors are independent

High number of new directors

Jiangsu Lanfeng Bio-chemical Co.,Ltd, Annual General Meeting, May 10, 2022

Recent updates

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Stock Catapults 107% Though Its Price And Business Still Lag The Industry

New minor risk - Share price stability

Third quarter 2024 earnings released: CN¥0.12 loss per share (vs CN¥0.11 loss in 3Q 2023)

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024

Benign Growth For Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Underpins Its Share Price

Second quarter 2024 earnings released: CN¥0.32 loss per share (vs CN¥0.20 loss in 2Q 2023)

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report First Half, 2024 Results on Aug 06, 2024

Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

First quarter 2024 earnings released: CN¥0.082 loss per share (vs CN¥0.043 loss in 1Q 2023)

Jiangsu Lanfeng Bio-chemical Co.,Ltd, Annual General Meeting, May 23, 2024

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

The Market Doesn't Like What It Sees From Jiangsu Lanfeng Bio-chemical Co.,Ltd's (SZSE:002513) Revenues Yet As Shares Tumble 26%

New minor risk - Share price stability

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: CN¥0.11 loss per share (vs CN¥0.006 loss in 3Q 2022)

New major risk - Financial position

Second quarter 2023 earnings released: CN¥0.20 loss per share (vs CN¥0.004 profit in 2Q 2022)

Jiangsu Lanfeng Bio-Chemical Co.,Ltd Approves Management Elections

New minor risk - Share price stability

Zheng Xu acquired a 18.04% stake in Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) from Jiangsu Suhua Group Co., Ltd. and Suzhou Gelin Investment Management Co., Ltd. for approximately CNY 300 million.

Zheng Xu acquired a 18.04% stake in Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) from Jiangsu Suhua Group Co., Ltd. and Suzhou Gelin Investment Management Co., Ltd. for approximately CNY 300 million.

Full year 2022 earnings released: CN¥0.88 loss per share (vs CN¥1.44 loss in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.076 loss in 3Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.003 (vs CN¥0.004 in 1Q 2021)

High number of new directors

Jiangsu Lanfeng Bio-chemical Co.,Ltd, Annual General Meeting, May 10, 2022

Full year 2021 earnings released: CN¥1.44 loss per share (vs CN¥0.04 profit in FY 2020)

Third quarter 2021 earnings released: CN¥0.076 loss per share (vs CN¥0.06 profit in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.04 loss per share (vs CN¥0.017 profit in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.004 (vs CN¥0.05 loss in 1Q 2020)

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day low: CN¥3.50

New 90-day low: CN¥3.53

New 90-day low: CN¥3.90

New 90-day high: CN¥4.37

Third quarter earnings released

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report Q3, 2020 Results on Oct 23, 2020

New 90-day high: CN¥4.30

Taicang Yunzaifei Material Trading Co., Ltd. signed an agreement to acquire Taicang Lanfeng Chemical Co., Ltd. from Jiangsu Lanfeng Bio-chemical Co.,Ltd (SZSE:002513) for CNY 10.8 million.

New 90-day low - CN¥3.86

First half earnings released

Jiangsu Lanfeng Bio-chemical Co.,Ltd to Report First Half, 2020 Results on Aug 25, 2020

CEO

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age